{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/KROS/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T06:27:50.123Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10805,"canonical_name":"Keros Therapeutics, Inc.","cik":"0001664710","uei":null,"lei":null,"duns":null,"ticker":"KROS"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":35},"count":35,"timeline":[{"ts":"2026-09-11","kind":"sec.filing","form_type":"DEL AM","title":"DEL AM — Keros Therapeutics, Inc. — 2026-09-11","url_slug":"/sec/cik-0001664710/del-am/0001628280-26-061536","accession_number":"0001628280-26-061536","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Keros Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001664710/schedule-13g/0002052113-26-000752","accession_number":"0002052113-26-000752","importance":55},{"ts":"2026-07-15","kind":"sec.insider.p","reporter":"BIENAIME JEAN JACQUES","title":"","shares":1000,"price_per_share":10.61,"usd_value":10610,"security_title":"Common Stock","importance":50.01061},{"ts":"2026-07-06","kind":"sec.filing","form_type":"3","title":"3 — Keros Therapeutics, Inc. — 2026-07-06","url_slug":"/sec/cik-0001664710/3/0001797917-26-000005","accession_number":"0001797917-26-000005","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Keros Therapeutics, Inc. — 2026-07-06","url_slug":"/sec/cik-0001664710/4/0001797917-26-000007","accession_number":"0001797917-26-000007","importance":30},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Prener Anne","title":"","shares":13786,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-25","kind":"sec.filing","form_type":"8-K","title":"8-K — Keros Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001664710/8-k/0001664710-26-000036","accession_number":"0001664710-26-000036","importance":35},{"ts":"2026-06-15","kind":"sec.insider.p","reporter":"BIENAIME JEAN JACQUES","title":"","shares":1000,"price_per_share":10.19,"usd_value":10190,"security_title":"Common Stock","importance":50.01019},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — Keros Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001664710/4/0001866219-26-000007","accession_number":"0001866219-26-000007","importance":30},{"ts":"2026-06-11","kind":"sec.form144","reporter":"Newton Charles W.","title":"Director","shares":550,"usd_value":5473,"security_title":"Common","approx_sale_date":"2026-06-11","accession_number":"0001969223-26-000680","importance":40.0010945},{"ts":"2026-06-11","kind":"sec.insider.s","reporter":"Newton Charles W.","title":"","shares":550,"price_per_share":10.04,"usd_value":5522,"security_title":"Common Stock","importance":35.005522},{"ts":"2026-06-11","kind":"sec.filing","form_type":"144","title":"144 — Keros Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001664710/144/0001969223-26-000680","accession_number":"0001969223-26-000680","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Keros Therapeutics, Inc. — 2026-06-08","url_slug":"/sec/cik-0001664710/4/0001808296-26-000004","accession_number":"0001808296-26-000004","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Keros Therapeutics, Inc. — 2026-06-08","url_slug":"/sec/cik-0001664710/4/0001808365-26-000004","accession_number":"0001808365-26-000004","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Keros Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001664710/4/0001721020-26-000002","accession_number":"0001721020-26-000002","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Keros Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001664710/4/0001721020-26-000004","accession_number":"0001721020-26-000004","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Keros Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001664710/4/0001808296-26-000002","accession_number":"0001808296-26-000002","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Keros Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001664710/4/0001808365-26-000002","accession_number":"0001808365-26-000002","importance":30},{"ts":"2026-06-04","kind":"sec.form144","reporter":"Seth Alpna","title":"Director","shares":2625,"usd_value":28035,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001969223-26-000636","importance":40.005607},{"ts":"2026-06-04","kind":"sec.form144","reporter":"Knowles Julius","title":"Director","shares":2625,"usd_value":28035,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001969223-26-000637","importance":40.005607},{"ts":"2026-06-04","kind":"sec.form144","reporter":"Farzan Nima","title":"Director","shares":2625,"usd_value":28035,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001969223-26-000639","importance":40.005607},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Farzan Nima","title":"","shares":2625,"price_per_share":10.73,"usd_value":28166,"security_title":"Common Stock","importance":35.02816625},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Knowles Julius","title":"","shares":2625,"price_per_share":10.73,"usd_value":28166,"security_title":"Common Stock","importance":35.02816625},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Seth Alpna","title":"","shares":2625,"price_per_share":10.72,"usd_value":28140,"security_title":"Common Stock","importance":35.02814},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — Keros Therapeutics, Inc. — 2026-06-04","url_slug":"/sec/cik-0001664710/144/0001969223-26-000636","accession_number":"0001969223-26-000636","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — Keros Therapeutics, Inc. — 2026-06-04","url_slug":"/sec/cik-0001664710/144/0001969223-26-000637","accession_number":"0001969223-26-000637","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — Keros Therapeutics, Inc. — 2026-06-04","url_slug":"/sec/cik-0001664710/144/0001969223-26-000639","accession_number":"0001969223-26-000639","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Keros Therapeutics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001664710/8-k/0001664710-26-000034","accession_number":"0001664710-26-000034","importance":35},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"BIENAIME JEAN JACQUES","title":"","shares":7142,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"GRAY MARY ANN","title":"","shares":7142,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Seth Alpna","title":"","shares":7142,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Farzan Nima","title":"","shares":7142,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Knowles Julius","title":"","shares":7142,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Keros Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001664710/8-k/0001664710-26-000032","accession_number":"0001664710-26-000032","importance":35},{"ts":"2026-05-15","kind":"sec.insider.p","reporter":"BIENAIME JEAN JACQUES","title":"","shares":1000,"price_per_share":10.58,"usd_value":10580,"security_title":"Common Stock","importance":50.01058}]}